1. Dunlap HF, Kepler EJ. A syndrome resembling familial periodic paralysis occurring in the course of exophthalmic goiter. Endocrinology. 1931; 15:541–6.
Article
2. Loh KC, Pinheiro L, Ng KS. Thyrotoxic periodic paralysis complicated by near-fatal ventricular arrhythmias. Singapore Med J. 2005; 46:88–9.
3. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr, McManis PG. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med. 1989; 149:2597–600.
Article
4. Jung SY, Song KC, Shin JI, Chae HW, Kim HS, Kwon AR. A case of thyrotoxic periodic paralysis as initial manifestation of Graves' disease in a 16-year-old Korean adolescent. Ann Pediatr Endocrinol Metab. 2014; 19:169–73.
Article
5. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006; 35:663–86. , vii.
Article
6. Oh SB, Ahn J, Oh MY, Choi BG, Kang JH, Jeon YK, et al. Thyrotoxic periodic paralysis associated with transient thyrotoxicosis due to painless thyroiditis. J Korean Med Sci. 2012; 27:822–6.
Article
7. Kung AW. Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge. J Clin Endocrinol Metab. 2006; 91:2490–5.
8. Ryan DP, da Silva MR, Soong TW, Fontaine B, Donaldson MR, Kung AW, et al. Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell. 2010; 140:88–98.
Article
9. Li X, Yao S, Xiang Y, Zhang X, Wu X, Luo L, et al. The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis. BMC Neurol. 2015; 15:38.
Article
10. Park S, Kim TY, Sim S, Oh HS, Song E, Kim M, et al. Association of KCNJ2 genetic variants with susceptibility to thyrotoxic periodic paralysis in patients with Graves' disease. Exp Clin Endocrinol Diabetes. 2017; 125:75–8.
Article
11. Barahona MJ, Vinagre I, Sojo L, Cubero JM, Pérez A. Thyrotoxic periodic paralysis: a case report and literature review. Clin Med Res. 2009; 7:96–8.
Article
12. Falhammar H, Thorén M, Calissendorff J. Thyrotoxic periodic paralysis: clinical and molecular aspects. Endocrine. 2013; 43:274–84.
Article
13. Guerra M, Rodriguez del Castillo A, Battaner E, Mas M. Androgens stimulate preoptic area Na+,K+-ATPase activity in male rats. Neurosci Lett. 1987; 78:97–100.
Article
14. Chakrabarti S. Normokalemic thyrotoxic periodic paralysis with preserved reflexes- a unique case report. J Clin Diagn Res. 2015; 9:OD05–6.
Article
15. Ko GT, Chow CC, Yeung VT, Chan HH, Li JK, Cockram CS. Thyrotoxic periodic paralysis in a Chinese population. QJM. 1996; 89:463–8.
Article
16. Pothiwala P, Levine SN. Analytic review: thyrotoxic periodic paralysis: a review. J Intensive Care Med. 2010; 25:71–7.
Article
17. Manoukian MA, Foote JA, Crapo LM. Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes. Arch Intern Med. 1999; 159:601–6.
Article
18. Ahn MB, Jung YJ, Lee MH, Cho WK, Suh BK. A case of thyrotoxic periodic paralysis in a 16-year-old adolescent. Ann Pediatr Endocrinol Metab. 2012; 17:117–21.
Article
19. Wi JK, Lee HJ, Kim EY, Cho JH, Chin SO, Rhee SY, et al. Etiology of hypokalemic paralysis in Korea: data from a single center. Electrolyte Blood Press. 2012; 10:18–25.
Article
20. Cho TH, Kim SC, Kim SJ. A case of thyrotoxic periodic paralysis in 17-year-old adolescent. J Korean Child Neurol Soc. 2013; 21:68–72.